In vitro selection of mutant HDM2 resistant to nutlin inhibition
HDM2 binds to the p53 tumour suppressor and targets it for proteosomal degradation. Presently in clinical trials, the small molecule Nutlin-3A competitively binds to HDM2 and abrogates its repressive function. Using a novel in vitro selection methodology, we simulated the emergence of resistance by...
Main Authors: | , , , , , , , |
---|---|
Other Authors: | |
Format: | Journal Article |
Language: | English |
Published: |
2014
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/100150 http://hdl.handle.net/10220/18644 http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0062564 |